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Summary Open or uncontrolled studies have suggested that providing cancer patients with audiotapes of
their clinical interviews can improve information recall and reduce psychological distress. We tested these
hypotheses in a 'clinician-blind'. prospective. randomised controlled trial. A total of 117 patients newly
referred to a medical oncology clinic who were to be given 'bad news' had their consultations audiotaped.
Blind to the clinician. patients were randomly allocated to receive a copy of the tape to play at home or not
(control group). At 6 months follow-up. tape group patients reported positive attitudes to the audiotape and
were shown to recall significantly more information about their illness than did controls. Overall improvement
in psychological distress at I and 6 months follow-up, as measured with the 30-item General Health
Questionnaire and the Hospital Anxiety and Depression Scale was no different in the two groups. However, a
second-order interaction suggested that poor-prognosis patients were disadvantaged specifically by access to
the audiotape. with less improvement in psychological distress at 6 months follow-up than non-tape controls.
Patient access to audiotapes of clinical interviews promotes factual retention but does not reliably reduce
psychological distress and may be actively unhelpful in some subgroups of patients.
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The diagnosis and treatment of cancer causes psychological
distress to the patient (Hardman et al.. 1989). In particular.
the 'bad news' interview can be a potent source of distress
and has been the focus of research (Fallowfield. 1993). Busy
clinicians are not always good communicators (Maguire and
Faulkner. 1988). and cancer patients report high rates of
dissatisfaction with medical staff commumncation (Lloyd et
al.. 1984: Fallowfield et al.. 1986). Such dissatisfaction
predicts increased anxiety (Sensky et al.. 1989) and reduced
compliance with treatment (Stiles et al.. 1979). and may
influence long-term outcome (Fallowfield et al.. 1990). In-
formation which distresses the patient is often poorly
registered and forgotten (Fallowfield et al.. 1986).
The efficacy and acceptability of clinical interviews with
cancer patients can be improved by training clinicians in
counselling skills (Maguire and Faulkner. 1988) or by ensur-
ing that a relative sits in at the interview (Fallowfield et al..
1987). Information in the form of leaflets can help but is
non-specific. A novel approach to reducing distress and pro-
moting efficient information transfer is to provide the patient
with an audiotape of the 'bad news' interview (Rosenbaum
and Rosenbaum. 1986). Recent uncontrolled studies have
indicated that this procedure is liked by cancer patients
(Hogbin and Fallowfield. 1989: Deutsch, 1992). and an open.
controlled study has reported reduced anxiety and better
recall at follow-up (North et al.. 1992). We describe here a
randomised. clinician-blind trial to assess formally the accep-
tability of this technique and its efficacy in reducing distress
and promoting retention of facts.
Methods
The study was designed as as 'clinician-blind'. randomised.
controlled clinical trial and was approved by the Charing
Cross Hospital Ethical Committee. A total of 117 patients
were recruited prospectively from a consecutive series of
out-patients newly referred to the Medical Oncology Depart-
ment at Charing Cross Hospital. This department provides a
regional oncology service for a variety of neoplastic diseases.
and is a supraregional referral centre for specific forms of
cancer, such as gestational trophoblastic disease (GTD). Dur-
ing the period of the study there were no formal counselling
services available within the department.
Patients were eligible for the study if they were to be given
potentially distressing information, either: (i) newly diag-
nosed patients receiving -primary bad news' of the diagnosis
itself or (ii) patients with an established diagnosis in whom
initial treatment had so far been unsuccessful ('secondary bad
news'). Inclusion criteria also required a patient to be aged
between 21 and 75. to be able to speak and write in English
and to be free of primary or secondary brain disease.
Eligible patients were identified initially from referral in-
formation and approached while in the out-patient depart-
ment waiting for their first clinical consultation. The nature
of the study was explained to them and written consent
obtained to audiotape the consultation. In accordance with
normal departmental practice, each patient had two linked
clinical interviews with one of five clinicians (three consul-
tants and two senior registrars). the second a mean of 4
weeks after the first, in which information concerning diag-
nosis. treatment and prognosis was given. Both these inter-
views were audiotaped with the clinician instructed not to
change his or her normal interview routine. Immediately
following interview 1. each patient was allocated to a tape
(experimental) or no-tape (control) condition using the CRC
Clinical Trials Centre telephone randomisation service. The
clinician was blind to this randomisation. Those patients
randomised to the experimental group were given copies of
the interview tapes and encouraged to listen to them at
home. Cassette players were provided if needed. Copies of all
taped interviews were also retained by the research team and
transcribed.
Data were collected in three stages. Immediately prior to
the first clinical intervie,. demographic data were collected
and baseline measures of psychological symptoms were
made. For this, two instruments were administered: the 30-
item version of the General Health Questionnaire (Goldberg
and Williams. 1988) and the 14-item Hospital Anxiety and
Depression Scale (Zigmond and Snaith. 1983). both also
completed at the second and third stages. The GHQ-30 and
the HADS have been designed specifically for. and standar-
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were readministered immediately before the second intemew.
At stage 3, a mean of 5 months after baseline, a postal
follow-up was carried out. All patients were sent the GHQ-30
and HADS. Those in the tape group received an 'attitude to
tape' questionnaire (see Table I) to assess subjective res-
ponses. with each statement rated on a five-point scale, rang-
ing from 0 (strongly disagree) to 4 (strongly agree). An
'information retention' questionnaire was sent to both
groups, which required patients to recall what was said to
them during the consultation regarding particular aspects of
their diagnosis and treatment. Each patient's responses were
then compared with the transcript of the original, taped
interview to give a measure of proportion of accurate re-
call.
One aim of the study was to identify patient subgroups
who might be particularly helped by audiotape. In order to
examine the effects of prognosis. patients were split into two
broad prognostic categories prior to the data analysis: (a)
those with good-prognosis tumours. with a cure rate of more
than 70%. e.g. choriocarcinoma, germ cell tumours and
lymphomas: and (b) those with poor-prognosis tumours in-
cluding 'high-risk'. i.e. node-positive, post-operative breast
carcinoma and metastasised solid tumours.
After randomisation 63 patients were allocated a tape and
54 allocated to a control group. all of whom completed the
first stage. Before the second stage ten of the tape group
dropped out: two died. four refused to remain in the study.
two required no more treatment. one refused to take the tape
and one developed brain disease. Of the control group, six
dropped out at this time: two died. three required no more
treatment and one demanded to have a tape. Of the 53 tape
group patients who completed the second stage, before stage
3 a further four died, one refused the tape and two tape
failures occurred. In the control group out of the remaining
48 patients 11 more died, one had no more treatment and
one demanded a tape prior to stage 3. Thus, (including one
'refuser'. one 'demander' and two 'tape failures' for whom
second stage data were available) 49 tape and 36 control
group patients were followed up at the third stage. Of these.
a total of 46 tape group patients and 32 controls returned at
least one of the forms sent to them - response rates of 94%
and 89% respectively.
Data analysis
For the GHQ-30. 'Likert' type scoring (0. 1. 2. 3) was used
to give a less skewed distribution and more sensitive measure
of the change in scores at each stage of the study (Goldberg.
1986). Conventional scoring (0. 0. 1. 1) (Goldberg and Wil-
liams. 1988) was used in order to identify cases of psychiatric
morbidity. Where necessary. the GHQ data were log trans-
formed so that parametnrc tests could be employed. although
analysis predominantly involved the use of change scores.
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Because there were unequal numbers of patients on some
factors. a regression or unweighted means approach was
employed. The HADS scores (which were positively skewed)
were analssed with non-parametric tests. Ow%ing to patient
attrition. no more than tw~o stages of the study were
examined at a time (for between-subjects effects) to keep the
loss of data to a minimum. The analysis was conducted using
an intention to treat approach: all available data for each
patient (including drop-outs) were analysed according to the
original randomisation groups.
Results
The mean age of the tape group was 45.0 years (s.d. 15.8:
range 21-72) and of the control group was 44.3 years (s.d.
17.7: range 21-74). Forty of the tape group (63.5%) and 29
of the control group (53.7%) were women. Forty-five
(71.4%) of the tape group and 39 (72.3%) of the control
group were marred or cohabiting. A diverse range of cancer
diagnoses was included: GTD (tape group 32%. controls
22.2%): testicular tumours (tape group 11.1%. controls
24%): carcinoma of breast (tape group 14.3%. controls
11.1%): bowel (tape group 6.30%. controls 5.6%); ovary (tape
group 4.8%. controls 5.6%): lung (tape group 3.2%. controls
5.6%): other diagnoses (tape group 28.6%. controls 25.8%).
Prognostic categories were well matched: 47.6% of the tape
group and 50% of controls had a good prognosis. The
majority of each group received 'primary' (tape group 74.6%.
control 79.6%) rather than 'secondarv' bad news. By stage 3.
in the tape (n = 32) and non-tape (n = 46) groups. mean ages
were 41.6 and 39.2 years respectively: the proportions of
poor-prognosis cases were 310% and 39% respectively and the
proportions of females were 69% and 70% respectively.
Attitudes to tape
At stage 2 of the study. tape group patients (n = 63) were
asked whether or not they had listened to the tape thus far:
79% had. 54% in the company of relatives or friends. Atti-
tudes to tape data were available for 39 (85%) patients in the
tape group at stage 3. some of whom did not complete all
questions. All of this group had played the tape at least once.
The results showed that 76% of patients found their tapes
helpful (Table I). Sixteen per cent reported being upset by the
tape: two patients from the poor-prognosis category and four
from the good prognosis category. Ninety-four per cent
reported that it helped them remember facts they had forgot-
ten in the interview.
Information retention
Individual items of information successfully recalled bv the
tape group at stage 3 (n = 39) were compared with those
Table I Attitudes to tape questionnaire
I found the tape helpful
The tape upset me
I think others with cancer would
be helped by a tape
The tape reminded me of facts I
had forgotten in the interview
Doctors should use tapes more
often
The tape helped me tell relatives







Relatives and friends found the (n = 25)
tape useful

























20- and canlis -
P McHugh et al
recalled by the no tape group (n = 28). Not all questions
were answered bv all subjects. Transcripts of the original
interviews were analysed to itemise the information con-
veyed. against which accurate recall was measured. Tape
group patients correctly recalled more of the facts they had
been given concerning their diagnosis and treatment than did
control group patients (see Table II). This effect was statis-
tically significant for five of the nine categories of inform-
ation examined..
Aleasures ofpsychological distress
Women were more anxious on the HADS than men at stages
1 and 2: stage I men (n = 48). actual mean 6.0. median 5.0:
women (n = 69) actual mean 8.1. median 8.0; stage 2 men
(n = 42) actual mean 5.5. median 5.0; women (n = 59) actual
mean 7.4. median 7.0 (Mann-Whitney Z- 2.1; P = 0.02 for
both stages). No significant sex differences were found for
GHQ-30 scores at any stage using t-tests.
Significant improvement was found in mean scores over
time (stages 1-3, completers only) for GHQ-30 (n = 75)
mean scores (33.6 to 30.7 to 27.4 MANOVA repeated
measures f= 14.8. d.f. = 2, P = <0.00005) and anxiety mea-
sures (n = 77; mean ranks actual means 2.45/7.3 to 2.02/6.6
to 1.53/5.1, Friedman two-way ANOVA, i 32.3, d.f. 2,
P<0.00005), but not for depression (n= 77; mean rank/
actual means 2.13/4.05 to 2.06/3.9 to 1.81/3.2, Friedman
two-way ANOVA NS, > 4.2, d.f. 2, P = 0.11). The improve-
ment over time was not the result of drop-outs having higher
(worse) scores: in stage 2 completers mean GHQ-30 was 33.5
(s.d. 14.0) and in drop-outs before stage 2 (n = 16) mean
GHQ-30 was 30.7 (s.d. 14.0); in stage 3 completers mean
GHQ-30 was 30.6 (s.d. 14.2) and in non-completers (n = 23)
mean GHQ-30 was 32.0 (s.d. 16.0).
Using a GHQ-30 threshold score of 11, considered appro-
priate in physicaUly ill patients (Goldberg, 1986; Goldberg
and Williams, 1988), 30% of the patients were classified as
having psychiatric disorder at baseline, and 22% at stage 3
follow-up. Using a HADS threshold score of 10, with any
score above indicating probable psychiatric disorder (Zig-
mond and Snaith, 1983), HADS anxiety patients totalled
26% at baseline, faling to 10% at follow-up. Baseline HADS
depression cases amounted to 7% at baseline and 5% at
follow-up. Thus, most of the variance in the improvment
over time was im patients with anxiety rather than depres-
sion.
Effects of tape allocation
No significant differences were found in mean GHQ-30 and
HADS scores between tape and control groups at either
stage 2 or 3. using univariate Mann-Whitney U-tests. Two
one-way analyses of variance were performed next to check
for significant differences between allocation groups and the
change in GHQ-30 scores between stages I and 2, and
between stages 2 and 3. Again, there were no significant
differences (between stages 1 and 2 F= 0.09. P= 0.76:
between 2 and 3 F = 0.07. P = 0.79), indicating that the tape
had no detectable influence on the GHQ-30 scores of the
tape group as a whole, compared with the control group.
A main aim of the study was to identify demographic and
clinical subgroups of patients who might derive particular
benefit from access to audiotape. in terms of improving
GHQ-30 scores.
A two-way ANOVA of tape allocation and partner status
showed a significant main effect for partner status on GHQ
change scores from stage 1 to stage 2. Patients with partners
(n = 71) improved significantly more than those without part-
ners (n = 29): mean change partners,-4. 95% CI 6.7 to 1.7,
vs no partner. 1. 950% CI -3.2 to 5.5; F=5.25. P=0.02.
There were no second-order interaction effects between tape
allocation and partner status.
Five different clinicians participated in the study. each
seeing between 16 and 30 patients. No significant main effects
were found for clinician on GHQ-30 score change (two-way
ANOVA) or HADS scores at any stage (Kruskal- Wallis
tests). No second-order interactions for GHQ-30 were seen
between tape allocation and clinician at any stage.
There were no significant differences in mean baseline
GHQ scores between the two prognostic groups. A two-way
ANOVA between allocation and prognosis showed a
significant main effect for change in prognostic category from
stages 1 to 2 (F= 6.03. P = 0.016). with a greater improve-
ment in the good-prognosis group (mean change - 5.1, 95%
CI -8.1 to -2.0) than the poor-prognosis group (mean
change 0.2, 95% CI -2.8 to 3.2). There was no significant
second-order interaction with tape allocation at this stage
(F= 0.37; P = 0.54). From stage 2 to 3, the effect of prognos-
tic category continued but was no longer statistically
significant (good prognosis mean change -5.3, 95% CI
-8.9 to -2.31; poor-prognosis mean change -0.4, 95% CI
-4.7 to 6.5; F= 2.75; P= 0.10). However, a significant
second-order interaction emerged between prognostic group
and tape allocation: tape group-good-prognosis mean
change -8.0, 95% CI -12 to -3.9, tape group-poor-
prognosis mean change 5.3, 95% CI - 1.7 to 12; control
group-good-prognosis mean change -2.7, 95% CI -8.2 to
2.8, control group-poor-prognosis -6.3, 95% CI - 15 to
2.6; F = 8.34, P= 0.005 (see Table III). This second-order
interaction persisted (F = 7.75, P= 0.007) after a precau-
tionary analysis of covariance to control for any chance
differences in GHQ score at baseline (covariate F= 2.47,
P = 0.12). A further analysis of covariance was performed
for actual follow-up GHQ score, rather than change in score,
by tape group and prognostic category. In this, baseline score
significantly predicted final stage 3 follow-up score (covariate
F = 48.3, P = <0.0005). Tape allocation group had no main
effect (F = 0.07, P = 0.8). Prognostic group showed a
significant effect (F = 12.7, P = 0.001) and the second-order
interaction existed for the actual final score (F = 4.31,
P = 0.04) in the same way as for the change score, with poor
prognosis, tape group patients faring worst.
Table 11 Information from the first intemrew recalled by control (n = 28) vs tape (n = 39)
group patients at 6 months follow-up
Stage 3: percentage of
Stage 1: percentage of patients told who recalled
patients toldbY doctor correctl/
Tape No tape Tape No tape
Name of diagnosis or condition 95 90 94 81
Tests and results 87 96 91 67a
Name of treatment 97 93 100 81'
Other treatments 41 46 94 62a
Side-effects of treatment 97 86 89 67'
Effect of treatment on daily life 81 79 73 50
Length of treatment 95 86 94 79
Outlook for future 87 93 91 85
Specific instructions about 67 57 85 56a
self-care
aFisher's exact or chi-square one-tail P< 0.05.- Scwf - "'
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Table MII Change in GHQ-30 scores by tape allocation and prognostic category
Stage 2 Stage 3 Mean change
Tape group (n = 43,v
Good prognosis (n = 27) 34.0 (28.3 to 39.7) 26.0 (21.0 to 31.0) -8.0 (-12 to -3.9)
Poor prognosis (n = 16) 27.6 (22.3 to 33.0) 33.0 (23.5 to 42.4) 5.3 (-1.7 to 12)
No tape group (n = 32)
Good prognosis (n = 22) 28.2 (22.0 to 34.4) 25.5 (20.3 to 30.8) -2.7 (-8.2 to 2.8)
Poor prognosis (n = 10) 32.3 (18.7 to 46.0) 26.0 (17.8 to 34.2) -6.3 (-15 to 2.6)
Values are means (95% confidence intervals): reducing scores represent clinical improvement.
The acceptability and efficacy of audiotapes as aids to
memory and well-being were tested in a consecutive series of
patients attending a medical oncology clinic, to whom poten-
tially distressing clinical information ('bad news') was being
delivered. Previous studies have examined the effects of
audiotapes in settings limited to a single, highly motivated
clinician (Hogbin and Fallowfield, 1989), a single diagnostic
patient group (Lloyd et al., 1984) or the delivery of a stan-
dardised, structured set of information (North et al., 1992).
These design specifications reduce the number of confound-
ing factors and thus enable hypotheses to be tested in smaller
sample sizes, but limit any generalisability of findings to
everyday clinical situations. We chose to examine an
unmodified clinical setting, with five clinicians at senior regis-
trar and consultant grade. a variety of clinical diagnoses and
few constraints on the length, content or style of the inter-
view. Instead, such variables were noted or measured and
entered into a multivariate analysis.
A total of 117 patients were randomised and entered the
study at baseline. The hypothesis that audiotapes would
facilitate retention of clinical information in patients was
confirmed. A quantitative comparison of the information in
various categories that was recalled at follow-up, compared
with the actual information initially given by the clinician.
showed that in all nine categories of information those
patients allocated to the tape group recalled more than those
allocated to the control group, confirming results from ear-
lier, smaller studies that audiotapes improve memory for
factual information given in a clinical setting (Johnson and
Adelstein, 1991; Deutsch, 1992; Hogbin et al., 1992; Rylance.
1992). This effect may be particularly relevant to situations in
which the information is delivered in an emotionally charged
context, likely to impair registration. such as the giving of
bad news in an oncology clinic.
The potentially most important aim of the study was to
examine the plausible effect of replaying an audiotape on
reducing psychological distress. At baseline, 30% of the
overall sample qualified as cases on the GHQ-30, a figure
consistent with that of previous studies in cancer patients
(Cavanaugh and Wettstein, 1989). As in previous studies
(Ford et al., 1990; Moorey et al., 1991), most of this initial
morbidity comprised anxiety, cases of which on the HADS
fell from 26% to 19% to 10% at the end of the study. Sex
differences were demonstrated, as in epidemiological studies
(Cox et al., 1987), as was the protective effect of having a
partner. These differences confirmed that the instruments
used were sensitive to change in the study population. How-
ever, no main effect of having access to the audiotape could
be demonstrated in the sample as a whole, in terms of scores
on the GHQ-30 or Hospital Anxiety and Depression Scale.
either at the second stage of the study or at follow-up. An
unexpected second-order interaction (P = 0.005) was found
between prognostic group and tape allocation. Whereas all
good-prognosis patients, and those poor-prognostic patients
with no tape, were improved at follow-up, poor-prognosis
patients who received a tape had deteriorated in terms of
their GHQ scores. This effect was largely responsible for the
significant two-way interaction. Importantly, a similar finding
has recently been reported in a controlled study of using
audiotapes in a sample of 67 women with early breast cancer
(Hogbin et al., 1992). As in the current study, information
retention was found to be enhanced by the audiotape but no
main effect on reducing psychological morbidity was demon-
strable. However, in the conservative treatment group
specifically (wide local excision vs mastectomy). anxiety levels
increased in the tape group, causing the authors to speculate
that audiotapes might be unhelpful in patient groups who use
denial as a coping mechanism.
Thus, although tapes do indeed improve the factual reten-
tion of information, there is little to suggest that audiotaping
clinical interviews in cancer patients is effective in reducing
psychological distress in general. and in poor-prognosis
patients in particular. Although audiotapes may be a useful
adjunct to good clinical practice in good-prognosis patients,
and do certainly seem to be valued by the patients them-
selves, our findings suggest it is not valid to recommend their
use uncritically to all patients. The finding that poor-
prognosis patients may actually have a worse psychological
outcome if given the tape was not predicted and at first
seems counterintuitive, although the numbers were small in
these groups. However, there is considerable evidence to
suggest that the use of psychological defence mechanisms
such as denial is widely used in cancer patients over the
longer term and may paradoxically improve psychological
and even physical outcome (Greer. 1992). Although initial
disclosure of a cancer diagnosis and discussion about treat-
ment options is important, and there are no grounds for
withholding this information, re-exposure to distressing in-
formation may prevent the use of this adaptive defence
mechanism.
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